The settlement will end a dispute dating back more than two years and likely help CombiMatrix as it continues to seek "strategic options" for the company.
The agreement to issue additional shares settles claims brought against Sequenom for alleged breach of representations and warranties made by Sequenom in its asset purchase agreement.
The settlement ends a one-year-old dispute regarding mass-spec based patents held by Sequenom.
Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.
Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.
Slate's Jane Hu compares some at-home genetic tests to astrology.
In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.